EffRx Pharmaceuticals' Secondary Market Round

EffRx Pharmaceuticals raised a round of funding on February 26, 2018. Investors include Sobera Capital.

EffRx Pharmaceuticals exploits drug delivery technologies to improve the efficacy and tolerability of existing approved compounds with a focus on drugs, with high commercial potential. Once developed,…

Articles about EffRx Pharmaceuticals' Secondary Market Round: